A Phase II interventional study of LDRT, toripalimab, and chemotherapy in recurrent/metastatic nasopharyngeal carcinoma
Recruiting Phase 2 NCT07325539
Study Description
A study testing the combination of low-dose radiation therapy, immunotherapy, and chemotherapy for nose and throat cancer that has returned or spread
Study Details
- Registry ID:
- NCT07325539
- Conditions:
- Nasopharyngeal Cancinoma (NPC), Nasopharangeal Cancer
- Phase:
- Phase 2
- Target Enrollment:
- 55 participants
- Start Date:
- Age Range:
- 18–65 years
- Healthy Volunteers:
- No
Study Locations (2 sites)
-
Sun Yat-sen University Cancer Center
Guangzhou, Guangdong, China -
Cancer Hospital and Shenzhen Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College
Shenzhen, Guangdong, China
Interested in Participating?
Check your eligibility and learn more about this study on TrialScreen.